The surgical hemostats market size has grown strongly in recent years. It will grow from $3.93 billion in 2025 to $4.2 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to rising surgical procedures, demand for blood loss management, advancement in surgical instruments, increase in hospital infrastructure, awareness about patient safety.
The surgical hemostats market size is expected to see strong growth in the next few years. It will grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to innovation in hemostatic products, adoption of robotic-assisted surgeries, growth in outpatient surgical centers, integration of ai in healthcare, demand for biodegradable hemostats. Major trends in the forecast period include minimally invasive surgical techniques, advanced hemostatic materials development, point-of-care hemostasis monitoring, integration of ai in surgical planning, eco-friendly and sustainable surgical supplies.
The increasing number of trauma cases is expected to drive the growth of the surgical hemostats market in the near future. Trauma involves physical injury or emotional shock resulting from a distressing or harmful event, affecting an individual's body or mind. The rise in trauma cases is mainly due to a surge in road traffic accidents, which cause severe injuries needing immediate medical care. Surgical hemostats assist in quickly and effectively controlling bleeding during trauma cases, reducing blood loss and stabilizing patients for further treatment. For example, in 2023, the Wisconsin Department of Health Services reported that traumatic injuries caused by assault increased by 3% compared to 2022, rising from 1,544 cases to 1,584 cases. Hence, the growing occurrence of trauma cases is fueling the expansion of the surgical hemostats market.
Major companies operating in the surgical hemostat market are concentrating on creating advanced solutions, such as room-temperature-stable sealing patches, to improve bleeding control, optimize operating-room efficiency, and overcome challenges related to cold-chain storage. Room-temperature sealing patches are next-generation hemostatic pads designed to retain full functionality without the need for refrigeration, providing enhanced flexibility, quicker deployment, and better accessibility compared with conventional refrigerated or bulky sponge-based hemostats. For example, in May 2025, Baxter International Inc., a US-based healthcare company, launched the Hemopatch Sealing Hemostat RT, its newest collagen-based patch developed for effective hemostasis in both open and minimally invasive surgeries. The patch combines a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer that forms a hydrogel upon fluid contact, enabling fast tissue adhesion and sealing while supporting natural platelet activity. Achieving hemostasis generally within approximately two minutes, offering biocompatibility, and fully resorbing within 6-8 weeks, the product also provides practical benefits such as room-temperature storage and an extended 36-month shelf life, enhancing surgical workflow and supply-chain flexibility.
In May 2025, Merit Medical Systems, Inc., a US-based medical device company, acquired Biolife Delaware for $120 million. Through this acquisition, Merit Medical Systems aims to broaden its hemostasis product portfolio and reinforce its position in the global market for rapid bleeding control solutions. BioLife Delaware, L.L.C. is a US-based medical device firm specializing in the development of surgical hemostatic products.
Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH.
North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the surgical hemostats market by affecting the cost and availability of raw materials such as collagen, gelatin, and synthetic polymers used in hemostatic products. Increased tariffs have raised production costs, particularly for matrix and gel hemostats, flowable hemostats, and topical thrombin-based hemostats, impacting key regions like North America and Europe where imports are significant. While this has created challenges for manufacturers, it has also encouraged local production and sourcing strategies, potentially reducing dependency on imports and driving innovation in cost-effective hemostat solutions.
The surgical hemostats market research report is one of a series of new reports that provides surgical hemostats market statistics, including surgical hemostats industry global market size, regional shares, competitors with a surgical hemostats market share, detailed surgical hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the surgical hemostats industry. This surgical hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Surgical hemostats are specialized tools or substances used during surgery to control bleeding by either clamping blood vessels or encouraging blood clot formation. Their purpose is to maintain a clear surgical area and minimize blood loss, improving visibility and safety throughout the procedure.
The primary types of surgical hemostats include topical thrombin-based hemostats, flowable hemostats, collagen-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, combination hemostats, and others. Topical thrombin-based hemostats are applied directly to bleeding areas to stimulate clotting by converting fibrinogen into fibrin through the action of thrombin. These come in various forms such as matrix and gel, sponges, sheets and pads, and powders. They are used in a wide range of surgeries including neurological, orthopedic, cardiovascular, gynecological, trauma, and plastic surgeries. These products are utilized by various end users including hospitals, ambulatory surgical centers, specialty clinics, and more.
The surgical hemostats market consists of sales of mechanical hemostats, active hemostats, flowable hemostats, fibrin sealants, and combination hemostats. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The surgical hemostats market size is expected to see strong growth in the next few years. It will grow to $5.41 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to innovation in hemostatic products, adoption of robotic-assisted surgeries, growth in outpatient surgical centers, integration of ai in healthcare, demand for biodegradable hemostats. Major trends in the forecast period include minimally invasive surgical techniques, advanced hemostatic materials development, point-of-care hemostasis monitoring, integration of ai in surgical planning, eco-friendly and sustainable surgical supplies.
The increasing number of trauma cases is expected to drive the growth of the surgical hemostats market in the near future. Trauma involves physical injury or emotional shock resulting from a distressing or harmful event, affecting an individual's body or mind. The rise in trauma cases is mainly due to a surge in road traffic accidents, which cause severe injuries needing immediate medical care. Surgical hemostats assist in quickly and effectively controlling bleeding during trauma cases, reducing blood loss and stabilizing patients for further treatment. For example, in 2023, the Wisconsin Department of Health Services reported that traumatic injuries caused by assault increased by 3% compared to 2022, rising from 1,544 cases to 1,584 cases. Hence, the growing occurrence of trauma cases is fueling the expansion of the surgical hemostats market.
Major companies operating in the surgical hemostat market are concentrating on creating advanced solutions, such as room-temperature-stable sealing patches, to improve bleeding control, optimize operating-room efficiency, and overcome challenges related to cold-chain storage. Room-temperature sealing patches are next-generation hemostatic pads designed to retain full functionality without the need for refrigeration, providing enhanced flexibility, quicker deployment, and better accessibility compared with conventional refrigerated or bulky sponge-based hemostats. For example, in May 2025, Baxter International Inc., a US-based healthcare company, launched the Hemopatch Sealing Hemostat RT, its newest collagen-based patch developed for effective hemostasis in both open and minimally invasive surgeries. The patch combines a biodegradable bovine-dermis collagen matrix with a thin NHS-PEG layer that forms a hydrogel upon fluid contact, enabling fast tissue adhesion and sealing while supporting natural platelet activity. Achieving hemostasis generally within approximately two minutes, offering biocompatibility, and fully resorbing within 6-8 weeks, the product also provides practical benefits such as room-temperature storage and an extended 36-month shelf life, enhancing surgical workflow and supply-chain flexibility.
In May 2025, Merit Medical Systems, Inc., a US-based medical device company, acquired Biolife Delaware for $120 million. Through this acquisition, Merit Medical Systems aims to broaden its hemostasis product portfolio and reinforce its position in the global market for rapid bleeding control solutions. BioLife Delaware, L.L.C. is a US-based medical device firm specializing in the development of surgical hemostatic products.
Major companies operating in the surgical hemostats market are Thermo Fisher Scientific Inc, Danaher Corporation, Agilent Technologies Inc, PerkinElmer Inc, Mettler Toledo International Inc, Shimadzu Corporation, Waters Corporation, Bruker Corporation, HORIBA Ltd, JEOL Ltd, Anton Paar GmbH, Renishaw plc, Metrohm AG, Genedata AG, HunterLab Europe GmbH, Avantes B V, JASCO Corporation, Wasatch Photonics Inc, Lablicate GmbH, StellarNet Inc, LabWare Inc, SciY Software GmbH.
North America was the largest region in the surgical hemostats market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the surgical hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the surgical hemostats market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the surgical hemostats market by affecting the cost and availability of raw materials such as collagen, gelatin, and synthetic polymers used in hemostatic products. Increased tariffs have raised production costs, particularly for matrix and gel hemostats, flowable hemostats, and topical thrombin-based hemostats, impacting key regions like North America and Europe where imports are significant. While this has created challenges for manufacturers, it has also encouraged local production and sourcing strategies, potentially reducing dependency on imports and driving innovation in cost-effective hemostat solutions.
The surgical hemostats market research report is one of a series of new reports that provides surgical hemostats market statistics, including surgical hemostats industry global market size, regional shares, competitors with a surgical hemostats market share, detailed surgical hemostats market segments, market trends and opportunities, and any further data you may need to thrive in the surgical hemostats industry. This surgical hemostats market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Surgical hemostats are specialized tools or substances used during surgery to control bleeding by either clamping blood vessels or encouraging blood clot formation. Their purpose is to maintain a clear surgical area and minimize blood loss, improving visibility and safety throughout the procedure.
The primary types of surgical hemostats include topical thrombin-based hemostats, flowable hemostats, collagen-based hemostats, oxidized regenerated cellulose-based hemostats, gelatin-based hemostats, combination hemostats, and others. Topical thrombin-based hemostats are applied directly to bleeding areas to stimulate clotting by converting fibrinogen into fibrin through the action of thrombin. These come in various forms such as matrix and gel, sponges, sheets and pads, and powders. They are used in a wide range of surgeries including neurological, orthopedic, cardiovascular, gynecological, trauma, and plastic surgeries. These products are utilized by various end users including hospitals, ambulatory surgical centers, specialty clinics, and more.
The surgical hemostats market consists of sales of mechanical hemostats, active hemostats, flowable hemostats, fibrin sealants, and combination hemostats. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Surgical Hemostats Market Characteristics
3. Surgical Hemostats Market Supply Chain Analysis
4. Global Surgical Hemostats Market Trends and Strategies
5. Surgical Hemostats Market Analysis of End Use Industries
7. Global Surgical Hemostats Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Surgical Hemostats Total Addressable Market (TAM) Analysis for the Market
9. Surgical Hemostats Market Segmentation
10. Surgical Hemostats Market Regional and Country Analysis
11. Asia-Pacific Surgical Hemostats Market
12. China Surgical Hemostats Market
13. India Surgical Hemostats Market
14. Japan Surgical Hemostats Market
15. Australia Surgical Hemostats Market
16. Indonesia Surgical Hemostats Market
17. South Korea Surgical Hemostats Market
18. Taiwan Surgical Hemostats Market
19. South East Asia Surgical Hemostats Market
20. Western Europe Surgical Hemostats Market
21. UK Surgical Hemostats Market
22. Germany Surgical Hemostats Market
23. France Surgical Hemostats Market
24. Italy Surgical Hemostats Market
25. Spain Surgical Hemostats Market
26. Eastern Europe Surgical Hemostats Market
27. Russia Surgical Hemostats Market
28. North America Surgical Hemostats Market
29. USA Surgical Hemostats Market
30. Canada Surgical Hemostats Market
31. South America Surgical Hemostats Market
32. Brazil Surgical Hemostats Market
33. Middle East Surgical Hemostats Market
34. Africa Surgical Hemostats Market
36. Surgical Hemostats Market Competitive Landscape and Company Profiles
37. Surgical Hemostats Market Other Major and Innovative Companies
40. Surgical Hemostats Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Surgical Hemostats Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses surgical hemostats market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for surgical hemostats? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The surgical hemostats market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Topical Thrombin-Based Hemostats; Flowable Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats; Gelatin-Based Hemostats; Combination Hemostats; Other Product Types2) By Formulation: Matrix And Gel Hemostats; Sponge Hemostats; Sheet And Pad Hemostats; Powder Hemostats
3) By Application: Neurological Surgery; Orthopedic Surgery; Cardiovascular Surgery; Gynecological Surgery; Trauma; Plastic Surgery; Other Applications
4) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
Subsegments:
1) By Topical Thrombin-Based Hemostats: Human Thrombin-Based Hemostats; Bovine Thrombin-Based Hemostats; Recombinant Thrombin-Based Hemostats; Formulations Gel, Spray, Powder, Sponge2) By Flowable Hemostats: Gelatin Matrix With Thrombin; Collagen-Based Flowables; Synthetic Polymer-Based Flowables
3) By Collagen-Based Hemostats: Microfibrillar Collagen; Nonwoven Collagen Pads; Collagen Fleece Or Sheets
4) By Oxidized Regenerated Cellulose Based Hemostats: Woven Oxidized Regenerated Cellulose Fabric; Non-woven Oxidized Regenerated Cellulose Pads; Oxidized Regenerated Cellulose With Additives
5) By Gelatin-Based Hemostats: Gelatin Sponge; Gelatin Powder; Gelatin Foam With Thrombin
6) By Combination Hemostats: Gelatin + Thrombin; Collagen + Thrombin; Oxidized Regenerated Cellulose + Thrombin
7) By Other Product Types: Chitosan-Based Hemostats; Kaolin-Based Hemostats; Synthetic Peptide Hemostats; Plant-Derived Agents
Companies Mentioned: Thermo Fisher Scientific Inc; Danaher Corporation; Agilent Technologies Inc; PerkinElmer Inc; Mettler Toledo International Inc; Shimadzu Corporation; Waters Corporation; Bruker Corporation; HORIBA Ltd; JEOL Ltd; Anton Paar GmbH; Renishaw plc; Metrohm AG; Genedata AG; HunterLab Europe GmbH; Avantes B V; JASCO Corporation; Wasatch Photonics Inc; Lablicate GmbH; StellarNet Inc; LabWare Inc; SciY Software GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Surgical Hemostats market report include:- Thermo Fisher Scientific Inc
- Danaher Corporation
- Agilent Technologies Inc
- PerkinElmer Inc
- Mettler Toledo International Inc
- Shimadzu Corporation
- Waters Corporation
- Bruker Corporation
- HORIBA Ltd
- JEOL Ltd
- Anton Paar GmbH
- Renishaw plc
- Metrohm AG
- Genedata AG
- HunterLab Europe GmbH
- Avantes B V
- JASCO Corporation
- Wasatch Photonics Inc
- Lablicate GmbH
- StellarNet Inc
- LabWare Inc
- SciY Software GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.2 Billion |
| Forecasted Market Value ( USD | $ 5.41 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
